Black Friday: 20% off all orders with code BLACK20.

Peptide Pens

NAD+ Pen 500mg

$120.00

NAD+ 3 mL Pen

The Science, Simplified: NAD+ (nicotinamide adenine dinucleotide, oxidized form) is a critical coenzyme involved in cellular redox reactions and energy metabolism.

Product Specifications – NAD+ 500 mg 3 mL Pen

  • Total NAD+: 500 mg
  • Volume: 3 mL pre-filled pen
  • Clicks in the pen: 300
  • Volume per click: 0.01 mL
  • Dial range: 1–60 clicks per dispensing (0.01–0.60 mL)
  • Peptide per click: ≈1.67 mg NAD+
  • Concentration: ≈166.7 mg/mL
  • Purity: Research-grade, third-party tested (COA available)
  • Format: Ready-to-use multi-dose pre-filled pen

Key Research Focus: Cellular energy metabolism and redox research.

Physical Form & Solubility:

  • Appearance: Clear liquid
  • Solubility: Already in aqueous solution. Highly soluble; no reconstitution required.

Pen Format Details: The 3 mL pre-filled pen is a sterile, multi-dose delivery system designed for precise, consistent dispensing of the research compound. It features a sealed cartridge, dial-a-dose mechanism for accurate volume control, and a fine-gauge needle interface. The pen is ready for immediate laboratory use with no mixing or transfer steps required. Each pen is labeled with total content and lot-specific COA reference.

Stability & Handling Notes:

  • Refrigerated at 2–8°C (36–46°F). Practical shelf life is 4–6 weeks when protected from light and handled with aseptic technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 6 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.

NAD+ Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the NAD+ research overview

  1. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+PubMed 31572171
  2. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world settingPubMed 41704678
  3. Clinical Evidence for Targeting NAD TherapeuticallyPubMed 32942582
  4. Roles of NAD+ in Health and AgingPubMed 37848251
  5. NAD+ therapy in age-related degenerative disorders: a benefit/risk analysisPubMed 31917996
NAD+ — dinucleotide structure
NAD+ — dinucleotide structure